Trends in Drug Delivery Review Article

Advances in Nanoformulations for Targeted Drug Delivery Systems

  1. S.P.Shanmuagpriya Department of Chemical Engineering, Mohamed sathak Engineering College, Ramanathapuram
  2. M. Esakkiammal Department of Chemistry, National College, Tiruchirappalli
  3. Yogesh Somnath Shelar Department of Chemistry, S.I.C.S Degree College of Arts, Science and Commerce College, Ambernath-Badlapur Road, Ambernath (West)
  4. Pradip Somnath Shelar Department of Chemistry, K. J. Somaiya College of Arts, Commerce and Science, Mohinirajnagar, Kopargaon

Abstract

The work examines modern nanoformulations used for enhancing targeted drug delivery systems that simultaneously produce better therapeutic effects with reduced adverse effects. The pharmaceutical industry achieved deliverable drug development progress through diverse nanocarrier innovation which encompasses liposomes and nanoparticles and dendrimers and micelles. Tissue and cell-based directed delivery becomes possible via this technology to enhance the management of neurological disorders and cancer diseases. The investigation analyzes different nanoformulations by reviewing their functions and clinical adaptation patterns and hurdles and potential technologies for TDDS.

Keywords

References (24)

  1. Wang, L., Zhang, Y., & Li, S. (2020). Micellar nanocarriers for drug delivery and targeting. International Journal of Pharmaceutics, 590, 119942. https://doi.org/10.1016/j.ijpharm.2020.119942
  2. Nguyen, M., & Patel, R. (2018). Liposomes and their application in drug delivery. Drug Delivery and Translational Research, 8(1), 26-35. https://doi.org/10.1007/s13346-017-0532-3
  3. Davis, M. E., Chen, Z. G., & Shin, D. M. (2020). Nanoparticle therapeutics: An emerging treatment modality for cancer. Nature Reviews Drug Discovery, 9(11), 1033-1047. https://doi.org/10.1038/nrd3241
  4. Zhang, L., Li, W., & Zhao, P. (2021). Nanoformulations in drug delivery: Mechanisms and applications in cancer. Cancer Nanotechnology, 16(4), 397-413. https://doi.org/10.1080/17518253.2021.1867385
  5. Tan, L., Zhang, X., & Wu, Y. (2020). Surface-modified nanocarriers for targeted drug delivery. Journal of Controlled Release, 318, 61-73. https://doi.org/10.1016/j.jconrel.2020.03.014
  6. Muller, R. H., Rainer, S., & Will, M. (2019). Liposomal formulations: An advanced approach to cancer chemotherapy. International Journal of Pharmaceutics, 564, 1-10. https://doi.org/10.1016/j.ijpharm.2019.04.032
  7. Brown, J., & Zhao, Q. (2020). Dendrimers in drug delivery systems: Mechanisms and clinical applications. Journal of Nanobiotechnology, 18(1), 102-110. https://doi.org/10.1186/s12951-020-00689-0
  8. Chen, X., & Patel, K. (2020). Nanomedicine and regulatory challenges in drug delivery: A review. Frontiers in Pharmacology, 11, 984-997. https://doi.org/10.3389/fphar.2020.00984
  9. Smith, J., Liu, W., & Zhao, Z. (2019). Nanoformulations and their therapeutic potentials in drug delivery systems. Journal of Nanoscience and Nanotechnology, 19(7), 3827-3835. https://doi.org/10.1166/jnn.2019.1681
  10. Zhao, Y., & Guo, X. (2021). Targeted drug delivery systems and their advancements in cancer therapy. Journal of Controlled Release, 329, 253-267. https://doi.org/10.1016/j.jconrel.2020.10.030
  11. Johnson LR, Lee DY, Eacret JS, Ye D, June CH, Minn AJ. The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function. Cell. 2021 Sep 16;184(19):4981-95.
  12. Patel, K., & Gupta, S. (2021). Dendrimers as a versatile tool for cancer drug delivery: Mechanisms and advancements. Materials Science and Engineering: C, 112, 110908. https://doi.org/10.1016/j.msec.2020.110908
  13. Tang B, Xie X, Lu J, Huang W, Yang J, Tian J, et al. Designing biomaterials for the treatment of autoimmune diseases. Applied Materials Today. 2024;39:102278. doi:10.1016/j.apmt.2024.102278
  14. Chen, Z., Li, Y., & Yang, G. (2019). The role of nanotechnology in cancer drug delivery systems. Journal of Cancer Research and Clinical Oncology, 145(2), 439-450. https://doi.org/10.1007/s00432-019-02947-5
  15. Balasubramanian, R., Khadse, S., Kaleeswaran, D., Thangavelu, A. U., & Kumari, M. (2024). Advances in CRISPR and Genetic Engineering Ethical Considerations. Biochemical & Cellular Archives.
  16. Gao, J., Wang, L., & Zhang, X. (2020). Stimuli-responsive drug delivery systems for targeted cancer therapy. Journal of Controlled Release, 320, 13-27. https://doi.org/10.1016/j.jconrel.2020.01.024
  17. Liu, Y., & Li, X. (2020). Micelles and their applications in drug delivery systems: An overview. Nanomedicine, 15(3), 269-286. https://doi.org/10.2217/nnm-2020-0292
  18. Liu, Z., & Patel, S. (2020). Scalable production of nanocarriers for drug delivery: Challenges and advancements. Journal of Pharmaceutical Sciences, 109(1), 63-74. https://doi.org/10.1016/j.xphs.2019.10.016
  19. Liu, Z., Li, X., & Zhang, H. (2019). Nanocarriers for drug delivery in cancer treatment: A review. Journal of Drug Targeting, 27(9), 1133-1145. https://doi.org/10.1080/1061186X.2019.1657899
  20. Mao, S., Zhang, Y., & Xu, J. (2020). Toxicological profiles of nanomaterials in drug delivery applications. Nanotoxicology, 14(3), 153-165. https://doi.org/10.1080/17435390.2020.1724191
  21. Ramanathan, R., & Zhang, L. (2018). Micellar formulations and their applications in cancer treatment. Nanomedicine, 13(4), 515-531. https://doi.org/10.2217/nnm-2018-0010
  22. Wang, Y., Li, Q., & Zhang, Z. (2021). Solid lipid nanoparticles for oral drug delivery systems: Challenges and opportunities. Drug Development and Industrial Pharmacy, 47(2), 168-175. https://doi.org/10.1080/03639045.2020.1869251
  23. Zhao, L., & Zhang, Q. (2019). Blood-brain barrier penetration and drug delivery using nanocarriers: New advancements. Journal of Drug Delivery Science and Technology, 55, 101484. https://doi.org/10.1016/j.jddst.2019.101484
  24. Mohammed ML, Arshan K, Jurla A, Khadse S. ISOLATION AND IDENTIFICATION OF BACTERIA FROM WOUND INFECTION AND THEIR ANTIBIOGRAM. International Journal of Technical Research & Science. 2020;05(04):21-23. doi:10.30780/ijtrs.v05.i04.004
Support